We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$48.6B
AUM Growth
+$1.55B
Cap. Flow
-$1.45B
Cap. Flow %
-2.99%
Top 10 Hldgs %
16.48%
Holding
2,644
New
42
Increased
557
Reduced
1,045
Closed
62

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$284M
2
HON icon
Honeywell
HON
+$171M
3
EA
Electronic Arts
EA
+$165M
4
MO icon
Altria Group
MO
+$162M
5
GWW icon
W.W. Grainger
GWW
+$156M

Top Sells

Rank Stock Value
1
LLL
L3 Technologies, Inc.
LLL
+$276M
2
ZTS icon
Zoetis
ZTS
+$211M
3
APH icon
Amphenol
APH
+$169M
4
AVGO icon
Broadcom
AVGO
+$163M
5
PEP icon
PepsiCo
PEP
+$162M

Sector Composition

Rank Sector Weight
1 Technology 20.49%
2 Healthcare 14.06%
3 Industrials 12.94%
4 Consumer Discretionary 12.93%
5 Financials 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNBR icon
2351
NN Inc
NNBR
$301M
$191K ﹤0.01%
12,222
VSTM icon
2352
Verastem
VSTM
$638M
$191K ﹤0.01%
2,192
+502
+30% +$49.9K
DGII icon
2353
Digi International
DGII
$3.17B
$190K ﹤0.01%
14,136
HLIT icon
2354
Harmonic Inc
HLIT
$1.24B
$190K ﹤0.01%
34,597
ESND
2355
DELISTED
Essendant Inc.
ESND
$187K ﹤0.01%
14,579
-30,193
-67% -$432K
AKBA icon
2356
Akebia Therapeutics
AKBA
$240M
$186K ﹤0.01%
21,035
LFCR icon
2357
Lifecore Biomedical
LFCR
$183M
$186K ﹤0.01%
12,937
NETI
2358
DELISTED
Eneti Inc.
NETI
$186K ﹤0.01%
2,761
LXRX icon
2359
Lexicon Pharmaceuticals
LXRX
$1.08B
$185K ﹤0.01%
17,314
TK icon
2360
Teekay
TK
$983M
$185K ﹤0.01%
27,413
MODN
2361
DELISTED
MODEL N, INC.
MODN
$185K ﹤0.01%
11,656
KDNY
2362
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$185K ﹤0.01%
5,047
SRNE
2363
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$185K ﹤0.01%
41,995
+8,237
+24% +$45.7K
UCTT
2364
Ultra Clean Holdings
UCTT
$3.9B
$184K ﹤0.01%
14,681
STML
2365
DELISTED
Stemline Therapeutics, Inc.
STML
$184K ﹤0.01%
11,069
CBIO
2366
Crescent Biopharma
CBIO
$620M
$183K ﹤0.01%
127
BHR
2367
Braemar Hotels & Resorts
BHR
$138M
$182K ﹤0.01%
15,583
PLUG icon
2368
Plug Power
PLUG
$3.1B
$182K ﹤0.01%
95,031
SUP
2369
DELISTED
Superior Industries International
SUP
$181K ﹤0.01%
10,627
KURA icon
2370
Kura Oncology
KURA
$882M
$180K ﹤0.01%
10,290
WSC icon
2371
WillScot Mobile Mini Holdings
WSC
$4.15B
$179K ﹤0.01%
+10,433
New +$171K
ONIT
2372
Onity Group
ONIT
$328M
$179K ﹤0.01%
3,031
GLDD
2373
DELISTED
Great Lakes Dredge & Dock
GLDD
$178K ﹤0.01%
28,777
TCRT icon
2374
Alaunos Therapeutics
TCRT
$4.81M
$178K ﹤0.01%
371
ONDK
2375
DELISTED
On Deck Capital, Inc.
ONDK
$178K ﹤0.01%
23,527

Similar funds

VOYA Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, VOYA Investment Management held 2,644 positions worth $48.6B, up 3.3% from $47B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.9%. VOYA Investment Management opened 42 new positions and exited 62, leaving the 2,644-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • VOYA Investment Management's largest Q3 2018 buy was Vanguard Global ex-US Real Estate ETF: 1,294,352 shares worth $72.7M.
  • VOYA Investment Management added most to Biogen in Q3 2018, an estimated $284M increase.
  • VOYA Investment Management's biggest Q3 2018 reduction was L3 Technologies, Inc., cutting an estimated $276M.
  • VOYA Investment Management fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q3 2018, selling an estimated $59M.
  • VOYA Investment Management's ten largest holdings make up 16% of its $48.6B portfolio in Q3 2018.
  • VOYA Investment Management opened 42 new positions and closed 62 in Q3 2018.
  • VOYA Investment Management's portfolio value rose 3.3% quarter-over-quarter to $48.6B.

Based on VOYA Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.